Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BraskemBAK +0.51%53 3-Year EBITDA Growth Rate is -4.50% as of Jun. 2026. GuruFocus rates BAK with a GF Score™ of 53/100 and a GF Value™ of $5.14 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 1,408 Chemicals companies, Braskem ranks worse than 59.16% on this metric.
During the past 12 months, Braskem's average EBITDA Per Share Growth Rate was 681.40% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was -4.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Braskem was 191.40% per year. The lowest was -87.70% per year. And the median was 0.00% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Braskem 3-Year EBITDA Growth Rate Related Terms
BAK vs DOW: 3-Year EBITDA Growth Rate Comparison
For the Chemicals subindustry, Braskem's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Braskem 3-Year EBITDA Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Braskem's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Braskem's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of -4.50% mean?
Braskem (BAK) has a 3-Year EBITDA Growth Rate of -4.50% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Braskem and its competitors. According to the industry distribution chart, Braskem ranks #833 out of 1408 companies in the Chemicals industry, placing it in the top 59.2%.
Is Braskem's 3-Year EBITDA Growth Rate too high?
Braskem's current 3-Year EBITDA Growth Rate is -4.50%. Based on the distribution chart, Braskem ranks #833 out of 1408 companies in the Chemicals industry, which is below the industry midpoint. Overall, Braskem has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Braskem's 3-Year EBITDA Growth Rate compare to DOW?
According to the Chemicals industry distribution chart, Braskem ranks #833 out of 1408 companies for 3-Year EBITDA Growth Rate. This places Braskem in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 0.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Chemicals company?
The median 3-Year EBITDA Growth Rate among Chemicals companies is 0.80, based on 1,408 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Braskem and its competitors. For the Chemicals industry, the median 3-Year EBITDA Growth Rate is 0.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Braskem's current 3-Year EBITDA Growth Rate is -4.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Braskem stock overvalued right now?
Based on GuruFocus' analysis, Braskem (BAK) is currently considered Possible Value Trap. The stock's GF Value™ is $5.14, compared to a current price of $1.99 — trading 61.3% below its estimated fair value. The current 3-Year EBITDA Growth Rate is -4.50%. Braskem's overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Braskem (BAK), the current 3-Year EBITDA Growth Rate is -4.50% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Braskem (BAK) Overvalued in 2026?
Based on GuruFocus' analysis, Braskem stock appears to be undervalued.
The current stock price of $1.99 is trading 61.3% below its estimated GF Value™ of $5.14.
GuruFocus considers Braskem to be Possible Value Trap.
Key valuation signals for BAK:
3-Year EBITDA Growth Rate: -4.50%
GF Value™: $5.14 vs. price of $1.99 (61.3% below fair value)
No single metric tells the full story. See the BAK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Braskem SA is engaged in the manufacture, sale, import and export of chemicals, petrochemicals and fuels, as well as the production, supply and sale of utilities such as steam, water, compressed air and industrial gases. It also provides industrial services and is engaged in the production, supply and sale of electric energy and gas for its own use and use by other companies. Its segments include Brazil, USA and Europe; and Mexico. The Brazil segments delivered the majority of the revenue from the production and sale of chemicals; the supply of electricity and other inputs produced in these complexes to second-generation producers located in the petrochemical complexes; and the production and sale of PE, including the production of green PE made from renewable resources, and of PP.
53GF Score
Get the complete analysis for BAK
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BAK has been successfully added to your 
